OSAMA SAYEGH: Open Payments
NPI 1235196320 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 32 payments from 10 companies in 2025. Trend: 2023 $961 · 2024 $709 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $162 |
| Novo Nordisk Inc | 6 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Amneal Pharmaceuticals LLC | 2 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Braeburn Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Abbott Laboratories | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $25 |
Products named: CAPLYTA, TRELEGY ELLIPTA, CREXONT, Ozempic, BREZTRI, BRIXADI, SHINGRIX, Rybelsus.
Industry payments across NY — which companies pay providers there.
